No Data
No Data
Illumina to Preview Newest Innovations in NGS and Multiomic Technologies at the American Society of Human Genetics Annual Meeting
Earnings Preview: Illumina to Report Financial Results Post-market on November 04
RBC Capital Maintains Illumina(ILMN.US) With Buy Rating, Maintains Target Price $252
Illumina Introduces the MiSeq I100 Series: Its Simplest, Fastest Benchtop Sequencers
Market Chatter: Fortrea Holdings Shares Rise Pre-Bell on Reports Activist Corvex Takes Stake
Illumina (NASDAQ:ILMN) Investors Are Sitting on a Loss of 64% If They Invested Three Years Ago
No Data
No Data